Phibro Animal HealthPAHC
About: Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Employees: 1,940
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
40% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 15
32% more capital invested
Capital invested by funds: $345M [Q2] → $457M (+$112M) [Q3]
14% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 49
4% more funds holding
Funds holding: 140 [Q2] → 146 (+6) [Q3]
1.44% less ownership
Funds ownership: 101.18% [Q2] → 99.74% (-1.44%) [Q3]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Barclays Balaji Prasad 43% 1-year accuracy 18 / 42 met price target | 13%downside $20 | Underweight Maintained | 12 Nov 2024 |
JP Morgan Ekaterina Knyazkova 0 / 0 met price target | 4%downside $22 | Neutral Initiated | 10 Sept 2024 |
Financial journalist opinion
Based on 17 articles about PAHC published over the past 30 days
